Close Menu

The story has been corrected to say that the Nasdaq Biotechnology Index rose 7 percent in February, not 10 percent. We apologize for for the mistake. 

NEW YORK (360Dx) — Foundation Medicine, Invitae, Accelerate Diagnostics, and Myriad Genetics each saw their share prices jump more than 20 percent in February to pace the gainers in the 360Dx Index last month.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.